Stonepine Capital Management »

Onkure Therapeutics Inc-a shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $549k 133k 4.14

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
Prosight Management
BVF
Vivo Capital
Vestal Point Capital
Foresite Capital Management VI
Adage Capital Partners GP
Sio Capital Management
Vanguard Capital Management
NEA Management Company
Rosalind Advisors
Renaissance Technologies

View all funds holding Onkure Therapeutics Inc-a